Physician profile
Deborah E Gravil
NPI 1225328040
$6,775.19
in general payments reported to CMS, 2019-2025
52 companies · $2,118 in 2025
The $2,118 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,204 · 2022: $1,480 · 2023: $783 · 2024: $1,189 · 2025: $2,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,090.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $675.27 | 2021-2024 | |
| Amgen INC. | $577.96 | 2021-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $401.65 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $338.16 | 2021-2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $326.43 | 2021-2025 | Onpattro, Amvuttra |
| Grifols USA, LLC | $290.27 | 2021-2025 | Prolastin-C Liquid |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $264.03 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $257.84 | 2021-2025 | Farxiga, Brilinta |
| Abiomed | $256.43 | 2024-2025 | Impella |
| Baxter Healthcare | $254.11 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Carnation Ambulatory Monitor, Hillrom - Vest System Model 105 Home Care |
| E.R. Squibb & Sons, L.L.C. | $211.53 | 2025 | Camzyos, Eliquis |
| Abbott Laboratories | $175.47 | 2021-2025 | Amplatzer Amulet, Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.04 | 2021-2025 | Jardiance, Ofev |
| Abbvie INC. | $141.78 | 2022-2025 | |
| Axsome Therapeutics, INC. | $138.66 | 2023-2025 | Auvelity, Sunosi |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $131.43 | 2022-2024 | Opsumit, Uptravi |
| Mallinckrodt Hospital Products INC. | $130.22 | 2021-2024 | Acthar |
| Verona Pharma, INC. | $121.94 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $117.70 | 2021-2023 | |
| Phathom Pharmaceuticals, INC. | $114.60 | 2025 | Voquezna |
| La Jolla Pharmaceutical Company | $111.39 | 2024-2025 | Giapreza |
| Kiniksa Pharmaceuticals International, Plc | $109.57 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $108.01 | 2021-2025 | Keytruda, Recarbrio, Dificid |
| Bayer Healthcare Pharmaceuticals INC. | $104.01 | 2022-2025 | |
| Philips North America LLC | $99.32 | 2022-2024 | (Ck4) Mcot, (Ak6) Vest Therapy |
| Vital Connect, INC | $92.38 | 2025 | Vitalpatch Rtm |
| Amarin Pharma, INC. | $91.79 | 2021-2022 | |
| Boston Scientific Corporation | $83.50 | 2022-2025 | Cds - Mct/Cem Monitoring, Bodyguardian |
| Novo Nordisk INC | $83.35 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Corcept Therapeutics | $75.07 | 2025 | Korlym |
| United Therapeutics Corporation | $71.05 | 2024-2025 | Tyvaso, Tyvaso |
| Vifor Pharma, INC. | $70.64 | 2024-2025 | Zemaira |
| Agile Therapeutics, INC. | $59.94 | 2021 | |
| Zoll Circulation INC | $58.77 | 2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Edwards Lifesciences Corporation | $58.09 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Ultragenyx Pharmaceutical INC. | $54.50 | 2022 | |
| Esperion Therapeutics, INC. | $50.63 | 2021-2022 | |
| Chiesi USA, INC. | $43.78 | 2021-2025 | Kengreal, Cleviprex |
| Harmony Biosciences LLC | $32.39 | 2024 | |
| Shockwave Medical, INC | $30.86 | 2021-2022 | |
| Akcea Therapeutics, INC. | $26.22 | 2021 | |
| Pharming Healthcare, INC. | $22.70 | 2023 | Ruconest |
| Jazz Pharmaceuticals INC. | $19.01 | 2025 | |
| Altathera Pharmaceuticals LLC | $18.66 | 2023 | Sotalol Hydrochloride |
| Csl Behring | $16.52 | 2025 | Kcentra |
| Kiniksa Pharmaceuticals, Ltd. | $15.60 | 2023 | Arcalyst |
| Glaxosmithkline, LLC. | $15.52 | 2025 | Shingrix, Arexvy |
| Inari Medical, INC. | $15.32 | 2022 | |
| Electromed, INC. | $13.61 | 2024 | Smartvest |
| Cvrx, INC. | $13.06 | 2023 | Barostim Neo System |
| Kowa Pharmaceuticals America, INC. | $12.31 | 2021 | |
| Amryt Pharma Holdings Ltd | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Gravil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.